Thomas G Roberts Jr
Overview
Explore the profile of Thomas G Roberts Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
765
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
3.
Dreyfuss P, Roberts Jr T
Oncologist
. 2011 Dec;
16(12):1672-4.
PMID: 22147001
No abstract available.
4.
Miksad R, Gonen M, Lynch T, Roberts Jr T
J Clin Oncol
. 2009 Mar;
27(13):2245-52.
PMID: 19307513
Purpose: When successive randomized trials contradict prior evidence, clinicians may be unsure how to evaluate them: Does accumulating evidence warrant changing practice? An increasingly popular solution, Bayesian statistics quantitatively evaluate...
5.
Schachter A, Ramoni M, Baio G, Roberts Jr T, Finkelstein S
Value Health
. 2007 Sep;
10(5):377-85.
PMID: 17888102
Objective: To evaluate the economic impact of a Bayesian network model designed to predict clinical success of a new chemical entity (NCE) based on pre-phase III data. Methods: We trained...
6.
Roberts Jr T, Barry M, Skarin A
Clin Adv Hematol Oncol
. 2005 Nov;
1(8):486-7.
PMID: 16258437
No abstract available.
7.
Chabner B, Roberts Jr T
Nat Rev Cancer
. 2005 Jan;
5(1):65-72.
PMID: 15630416
The era of chemotherapy began in the 1940s with the first uses of nitrogen mustards and antifolate drugs. Cancer drug development since then has transformed from a low-budget, government-supported research...
8.
Roberts Jr T, Goulart B, Squitieri L, Stallings S, Halpern E, Chabner B, et al.
JAMA
. 2004 Nov;
292(17):2130-40.
PMID: 15523074
Context: In the past, cancer patients entering phase 1 studies confronted the prospects of high risk and unlikely benefit. Over the last decade, cancer drugs under development have become more...
9.
Roberts Jr T, Chabner B
N Engl J Med
. 2004 Jul;
351(5):501-5.
PMID: 15282359
No abstract available.
10.
Roberts Jr T, Lynch Jr T, Chabner B
J Clin Oncol
. 2003 Sep;
21(19):3683-95.
PMID: 14512401
Purpose: To review characteristics of contemporary phase III oncology trials and create an explicit framework to help clinical researchers prioritize novel therapies for phase III testing. Methods: We searched the...